Crescent Capital BDCCCAP
Recorded

Crescent Capital BDC 2026 Q3 Earnings Call

Review the key takeaways and the transcript of this earnings call.

PeriodQ3 2026Duration39 minParticipants10

Transcript

Preview the first fifteen paragraphs, organized by speaker.

Operator

Good morning, and welcome to Crescent Capital BDC Inc.'s third quarter ended September 30, 2026, earnings conference call. Please note that Crescent Capital BDC Inc. may be referred to as CCAP, Crescent BDC, or the company throughout the call. I'll start with some important reminders. Comments made over the course of this conference call and webcast may contain forward-looking statements and are subject to risks and uncertainties. The company's actual results could differ materially from those expressed in such forward-looking statements for any reason, including those listed in its SEC filings. The company assumes no obligation to update any such forward-looking statement. Please also note that past performance or market information is not a guarantee of future results. I'll now turn the call over to Dan McMahon.

Dan McMahonSVP and Head of Investor Relations

Thank you. Yesterday, after the market closed, the company issued its earnings press release for the third quarter ended September 30, 2026, and posted a presentation to the investor relations section of its website, www.crescentbdc.com. The presentation should be reviewed in conjunction with the company's Form 10-Q filed yesterday with the SEC. As a reminder, this call is being recorded for replay purposes. Speaking on today's call will be CCAP's Chief Executive Officer, Jason Breaux, Chief Financial Officer, Gerhard Lombard, and President Henry Chung. With that, I'd now like to turn it over to Jason.

Jason BreauxCEO

Thank you, Dan, and good morning, everyone. I'll begin by reviewing our third quarter results, touch on the current market environment, and then outline our key priorities and some of the actions we're announcing today. For the third quarter, we reported net investment income of $0.37 per share, an increase from $0.36 per share in the prior quarter. Our earnings exceeded our $0.34 base dividend, and we also paid the second of our three previously announced special dividends of $0.03 per share during the quarter. Our net asset value remained largely stable at $17.72 per share as of September 30, compared with $17.82 at the end of the prior quarter. No new investments were placed on non-accrual during the quarter. Turning to the market, sponsor-backed M&A remained subdued during the third quarter.

Jason BreauxCEO

Direct lending volume supporting leveraged buyouts was down roughly 21% from the prior quarter and 60% from the third quarter of last year. While limited new buyout activity has moderated new platform financing opportunities and delayed some realizations, demand continues through add-on acquisitions, refinancings, and other needs within existing sponsor portfolios. Add-on financings remain an important source of activity for Crescent. Our private credit platform includes more than 250 lower middle market portfolio companies, providing a foundation for originations beyond new LBO transactions. Over the last 12 months, add-on financings accounted for approximately 50% of Crescent's total deal count and 25% of total dollars committed. Competition for attractive credit remains, even as portions of the non-traded BDC market continue to face redemption pressure. In this environment, our longstanding sponsor relationships and familiarity with existing borrowers allow us to remain selective on credit quality, structure, and pricing.

Jason BreauxCEO

Despite subdued new activity, the Crescent private credit platform remained active, committing approximately $1.5 billion of capital during the third quarter. As we emphasized last quarter, CCAP remains an important part of Crescent's private credit platform. The permanent fee reductions implemented earlier this year demonstrate Crescent's economic commitment to those objectives. Today, we are building on that commitment with several actions designed to drive NAV accretion by capturing the current discount in our stock. First, our board has authorized a $50 million share repurchase program for the purpose of repurchasing shares of our common stock in the open market at certain thresholds below our net asset value per share in accordance with applicable law. We believe our current share price materially undervalues CCAP, making repurchases at substantial discounts to NAV a compelling use of available capital.

Jason BreauxCEO

In addition to the CCAP repurchase program, Crescent's parent entity, Sun Life, will purchase up to an additional $25 million of shares in the open market at certain thresholds below our net asset value per share in accordance with applicable law. This commitment underscores Sun Life's confidence in CCAP's long-term value and further strengthens the alignment of Sun Life, Crescent, and the leadership team with CCAP's shareholders. The timing, manner, price, and amount of any share repurchases under the CCAP repurchase program and the Sun Life purchase program will be determined by the company and Sun Life, respectively, in their respective discretion based upon the evaluation of economic and market conditions, stock price, applicable legal and regulatory requirements, and other factors. In order to accelerate share repurchase activity, we expect to announce the formation of an unconsolidated joint venture.

Jason BreauxCEO

The joint venture is expected to be seeded with approximately $150 million of performing first lien assets from CCAP. CCAP expects to commit $30 million of equity to the joint venture, along with a $30 million expected equity contribution from the joint venture equity partner. In addition to the equity contributions, the joint venture is expected to be capitalized with an ABL facility. We are targeting a low to mid-teens ROE at the joint venture, which we expect to be accretive to our gross yield. The joint venture is expected to be completed during the fourth quarter of 2026. CCAP expects to use the proceeds from the JV to reduce leverage to our target range and fund share repurchases. Together, we believe these actions support our deleveraging objectives and create opportunities for per-share accretion. Finally, I would like to highlight a recent announcement regarding Crescent's broader platform.

Jason BreauxCEO

On October 26th, Sun Life announced GreenOak, a unified global brand bringing together Crescent, BGO, InfraRed Capital Partners, SLC Fixed Income, and Advisors Asset Management. The platform represents approximately $326 billion in assets under management across credit, real estate, and infrastructure, supported by a global distribution network. The brand transition will take place over the next 12 months. On the fixed income side, GreenOak brings together Crescent's alternative credit expertise and SLC Fixed Income's investment-grade public and private credit capabilities, providing a broader range of investment solutions and opportunities for collaboration. For CCAP, our investment processes, investment committees, and investment personnel remain unchanged. We will continue to manage the portfolio with the same disciplined underwriting approach and focus on income generation and capital preservation, supported by the resources and reach of the broader GreenOak platform.

Jason BreauxCEO

With that, I will turn the call over to Gerhard to review our third-quarter financial results in more detail.

Gerhard LombardCFO

Gerhard. Thanks, Jason, and hello, everyone.

Gerhard LombardCFO

Net investment income was $0.37 per share for the third quarter, up from $0.36 in the second quarter, and covered our $0.34 per share regular dividend. Compared to the second quarter, total investment income increased by approximately $0.6 million to $36.9 million. Interest income increased by approximately $0.9 million to $35.6 million. This was offset by lower dividend income, which declined to approximately $0.9 million from $1.2 million, primarily reflecting lower distributions from the legacy Logan JV as the vehicle continues to run off and deleverage, as discussed in prior quarters. Total expenses and excise taxes remained stable at $23.2 million, with modestly higher financing costs offset by lower income and excise taxes and professional fees. Turning to the balance sheet, our investment portfolio totaled approximately $1.6 billion at fair value as of September 30.

Gerhard LombardCFO

Total net assets were $653 million, or $17.72 per share. On slide nine, we provide a graphical analysis of the quarter-over-quarter change in NAV. We recorded $0.06 per share of net realized losses, largely offset by reversals of previously recognized unrealized losses on those investments. Net unrealized depreciation, including these reversals, totaled $0.04 per share. Valuation movements reflected slight spread widening, while company-specific credit movements were broadly neutral. Overall, portfolio valuations were generally stable, with NAV per share changing from $17.82 to $17.72. Let's shift to our capitalization and liquidity. I am on slide 18. Our debt-to-equity ratio remained 1.42 times, or 1.36 times net of balance sheet cash, compared with 1.37 times net in the prior quarter.

Gerhard LombardCFO

Gross debt outstanding declined to approximately $924 million from $935 million, and cash equivalents, and restricted cash totaled approximately $36 million at quarter end. While leverage ended the quarter above our long-term target range, we continue to maintain sufficient liquidity, with approximately $247 million of cash and available borrowing capacity as of quarter end. We expect that pending portfolio realizations and the previously discussed joint venture will bring net leverage to within our target range by year-end. Our board declared a fourth-quarter dividend of $0.34 per share. We will also pay the third and final previously announced special dividend of $0.03 per share on December 15. A supplemental dividend framework remains in effect, although no supplemental dividend is payable for the quarter under that framework. With that, I will turn it over to Henry to discuss the portfolio.

Henry ChungPresident

Thanks, Gerhard. We ended the quarter with approximately $1.6 billion of investments at fair value across 190 portfolio companies. The portfolio remained highly diversified, with an average investment size of approximately 0.5% and 91% invested in senior first lien loans. The broader portfolio continues to perform generally in line with our underwriting expectations, with the majority of portfolio companies demonstrating resilient operating performance and year-over-year EBITDA growth. Approximately 84% of investments remained rated one or two, indicating performance at or above expectations. Our weighted average portfolio risk rating remained at 2.1, and weighted average interest coverage improved to 2.3 times. Turning to slide 16, our watch list increased modestly from 15% to 16% of the portfolio at fair value, driven by three-rated investments increasing from 12% to 13%. Investments rated four and five declined from approximately 3% to 2.4%. We had no new non-accruals during the quarter.

Henry ChungPresident

Non-accruals declined from 4.8% to 4.7% of debt investments at cost, reflecting the sale of a small legacy First Eagle investment previously on non-accrual. Measured against the total investment portfolio at cost, non-accruals were 4.4%. Moving to investment activity, with leverage currently above our target range, our new investment activity was limited during the third quarter in order to prioritize deleveraging. Gross deployment totaled $24 million, the majority of which consisted of follow-on investments in existing portfolio companies. Aggregate exits, sales, and repayments totaled approximately $39 million, resulting in net realizations of approximately $15 million for the quarter. With that, I'll turn it back to Jason for closing remarks.

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Log in to unlock every statement, the English original, and speaker-by-speaker history.

Log in for the full transcript

Other earnings calls that day

View calls from this day